Sellas Life Sciences Group Inc's Company Valuation
Currency: USD Updated: 2026-06-18
Previous score
9.32
Change
0
The current valuation score of Sellas Life Sciences Group Inc is 9.32, ranking 40 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -35.18, which is -98.93% below the recent high of -0.38 and -15.65% above the recent low of -40.69.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.